Profound hypotension following concomitant administration of tizanidine and lisinopril

被引:0
作者
Setzer, Kayla [1 ]
Baldwin, Nicholas [2 ]
Mersfelder, Tracey [3 ]
Kelly, Matthew [4 ]
机构
[1] Western Michigan Univ, Internal Med & Pediat, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA
[2] Ferris State Univ, Sch Pharm, Big Rapids, MI USA
[3] Ferris State Univ, Pharm Practice, Big Rapids, MI USA
[4] Western Michigan Univ, Homer Stryker MD Sch Med, Internal Med, Kalamazoo, MI USA
关键词
Drug interactions; Medical management;
D O I
10.1136/bcr-2024-262982
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tizanidine, a muscle relaxant, exerts its mechanism as a centrally acting alpha-2 adrenergic receptor agonist and binds to imidazoline receptors. Bradycardia and hypotension are adverse effects associated with alpha-2 adrenergic receptor agonists. A man in his 50s with a medical history of hypertension and chronic back pain presented with chest pain and hypertension. Pertinent medication history included metoprolol tartrate, lisinopril, hydralazine, hydrochlorothiazide and tizanidine and was continued. Following medication administration, the patient was hypotensive. Further episodes occurred that correlated with tizanidine administration and were more pronounced with concomitant lisinopril administration. Tizanidine was discontinued, and the hypotensive episodes resolved. Profound hypotension caused by a tizanidine-lisinopril drug interaction is rare but potentially life-threatening. This reaction scored a 4 on the Naranjo Adverse Drug Reaction Probability Scale and Drug Interaction Probability Scale. Providers should be aware of this potential adverse reaction from the combination of medications.
引用
收藏
页数:4
相关论文
共 31 条
  • [31] Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes
    Xu, Ru-jun
    Kong, Wei-min
    An, Xiao-fei
    Zou, Jian-jun
    Liu, Li
    Liu, Xiao-dong
    FRONTIERS IN PHARMACOLOGY, 2020, 11